0001872295-21-000001.txt : 20210714 0001872295-21-000001.hdr.sgml : 20210714 20210714163503 ACCESSION NUMBER: 0001872295-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20210714 DATE AS OF CHANGE: 20210714 EFFECTIVENESS DATE: 20210714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aditum Bio Fund 2, L.P. CENTRAL INDEX KEY: 0001872295 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-406276 FILM NUMBER: 211090548 BUSINESS ADDRESS: STREET 1: 1111 BROADWAY, SUITE 1300 CITY: OAKLAND STATE: CA ZIP: 94607 BUSINESS PHONE: (510) 227-2102 MAIL ADDRESS: STREET 1: 1111 BROADWAY, SUITE 1300 CITY: OAKLAND STATE: CA ZIP: 94607 D 1 primary_doc.xml X0708 D LIVE 0001872295 Aditum Bio Fund 2, L.P. 1111 BROADWAY, SUITE 1300 OAKLAND CA CALIFORNIA 94607 (510) 227-2102 DELAWARE None None Limited Partnership true 2021 N/A Aditum Bio GP 2, LLC 1111 Broadway, Suite 1300 Oakland CA CALIFORNIA 94607 Director The General Partner of the Issuer (the "General Partner") Joseph Jimenez 1111 Broadway, Suite 1300 Oakland CA CALIFORNIA 94607 Director Managing Director of the General Partner of the Issuer Mark Fishman 1111 Broadway, Suite 1300 Oakland CA CALIFORNIA 94607 Director Co-Founder and Chairman of the Scientific Advisory Board Praveena Kandula 1111 Broadway, Suite 1300 Oakland CA CALIFORNIA 94607 Director Managing Director of the General Partner of the Issuer Ilan Zipkin 1111 Broadway, Suite 1300 Oakland CA CALIFORNIA 94607 Director Managing Director of the General Partner of the Issuer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.7 false true false true false 0 250000000 0 250000000 false 0 0 0 0 The General Partner of the Issuer (or an affiliate thereof) is entitled to a management fee. false Aditum Bio Fund 2, L.P. /s/Joseph Jimenez Joseph Jimenez Managing Director of the General Partner of the Issuer 2021-07-14